Stock MOLN MOLECULAR PARTNERS AG
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Molecular Partners AG Nasdaq

Equities

MOLN

US60853G1067

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-31 EDT 		5-day change 1st Jan Change
3.6 USD -11.55% Intraday chart for Molecular Partners AG -5.26% -13.87%
06-01 Molecular Partners AG Presents Positive Data from Completed Phase 1 Trial of MP0317 (FAP X CD40 DARPin) Monotherapy in Patients with Advanced Solid Tumors At ASCO 2024 CI
04-29 Molecular Partners AG Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533's Proposed Mechanism of Action CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
MOLECULAR PARTNERS AG
Bio Therapeutic Drugs
-11.55%-5.26%-13.87%-45.45% - 125M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. MOLN Stock
  4. MOLN Stock
  5. Charts Molecular Partners AG
  6. Comparison Chart